Psoriasis is a heavy burden for both the physical and economic health of the nation, affecting about 7.5 million Americans. The annual cost for treating psoriasis in the U.S. in 2008 was $11.25 billion. The average cost per patient, estimated at $5500 per year, is much higher for more severe … Continue reading →
Vitamin D analogues are popular for the local treatment of psoriasis. The first compound approved in the U.S. was calcipotriene (brand name Dovonex) available as cream, ointment, and lotion (for the scalp) for twice daily application. It was modestly … Continue reading →
The answer to the question depends on the extent of training in dermatology and the individual physician’s comfort level in dealing with skin diseases. Currently, the definition of “primary care providers” includes family practitioners, internists, pediatricians, and gynecologists, but may be expanded to include nurse practitioners. The education of U.S. medical … Continue reading →
Cyclosporine (CS), a potent immunosuppressive peptide, was discovered by Sandoz in 1975. Clinical testing showed that it was very effective for preventing rejection of life-saving organ transplants such as kidney, heart, liver, and bone marrow. Investigators also noted the impressive ability of CS to clear up any psoriasis on the … Continue reading →
To better understand the concept of “dysplastic moles,” we must agree on definitions of terms. Dysplastic from dysplasia means abnormal development of tissue. A mole in this context usually refers to a growth in skin that may be pigmented, flesh-colored, flat or raised, hairy or non-hairy.
Rosai-Dorfman disease (RDD) is a rare disease characterized by proliferation of histiocytes in lymph nodes and other organs. Skin involvement occurs in about 10% of systemic cases, but more cases of skin-limited RDD are being recognized, especially in women, based on recent case reports and personal experience.
Psoriasis by Charles Camisa as published in Disease Management Project. This site provides access to the complete chapter from Current Clinical Medicine, Second Edition. Read the chapter. This page allows users to reference the entire medical book by chapter in the table of contents.
When I worked as a Dermatologist at the Cleveland Clinic, we encountered many patients who were either referred by an outside Dermatologist, or self-referred, for a second opinion on their diagnosis or treatment or both. Most patients would bring copies of their records for us to review, and invariably, … Continue reading →
Dermatitis herpetiformis (DH) is an autoimmune skin disease caused by eating wheat protein called gluten. It has nothing to do with the infection caused by the Herpes virus. In DH, the patient … Continue reading →
Dr. Camisa is board certified in dermatology and dermatological immunology, practicing medicine for over 30 years. He is Director of the Phototherapy Department at Riverchase Dermatology and an Affiliate Associate Professor of Dermatology at the University of South Florida in Tampa. He specializes in psoriasis, lichen planus, bullous diseases, connective tissue diseases, cutaneous T-cell lymphoma, and diseases of the mouth and lips. Dr. Camisa is a leading expert in psoriasis, bullous disease, and other complex skin conditions, and patients throughout the country seek his experience. More about Dr. Camisa...